Protext Mobility Stock Today
| TXTM Stock | USD 0.0007 0.0001 12.50% |
PerformanceVery Weak
| Odds Of DistressVery High
|
Protext Mobility is selling at 7.0E-4 as of the 19th of March 2025; that is 12.5 percent decrease since the beginning of the trading day. The stock's lowest day price was 7.0E-4. Protext Mobility has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 19th of December 2024 and ending today, the 19th of March 2025. Click here to learn more.
ProText Mobility, Inc., a biotech company, engages in the development of pharmaceutical botanical medicines. ProText Mobility, Inc. is a subsidiary of Planda Biotechnology, Inc. Protext Mobility is traded on OTC Exchange in the United States. The company has 1.72 B outstanding shares. More on Protext Mobility
Moving together with Protext Pink Sheet
Moving against Protext Pink Sheet
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Protext Pink Sheet Highlights
| CEO, Director | Roger BaylisDuffield |
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Protext Mobility [TXTM] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Nano-Cap' category with a current market capitalization of 1.72 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Protext Mobility's market, we take the total number of its shares issued and multiply it by Protext Mobility's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Protext Mobility conducts business under Healthcare sector and is part of Biotechnology industry. The entity has 1.72 B outstanding shares.
Protext Mobility currently holds about 732 in cash with (253.84 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Protext Mobility Probability Of Bankruptcy
Protext Mobility Risk Profiles
| Mean Deviation | 7.75 | |||
| Standard Deviation | 10.95 | |||
| Variance | 119.9 | |||
| Risk Adjusted Performance | (0.01) |
Protext Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Protext Mobility without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Backtesting Now
Portfolio BacktestingAvoid under-diversification and over-optimization by backtesting your portfolios |
| All Next | Launch Module |
Other Information on Investing in Protext Pink Sheet
Protext Mobility financial ratios help investors to determine whether Protext Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Protext with respect to the benefits of owning Protext Mobility security.